HHS Open Government Plan Offers Vastly More Information On FDA, CMS
This article was originally published in The Gray Sheet
Executive Summary
The Department of Health and Human Services' open government plan, unveiled April 7, includes an online "FDA Track" site to measure FDA's performance and a "CMS Dashboard" that provides easier access to certain Medicare payment data
You may also be interested in...
TEDMED In Brief
Last week's TEDMED conference in Washington, D.C., touted as a gathering of visionaries imagining the future of health and medicine, welcomed U.S. Chief Technology Officer Todd Park and a host of other medtech policymakers and entrepreneurs.
Regulatory News In Brief
Office of Device Evaluation annual report: The device review office's fiscal 2009 annual report, released Sept. 2, paints a more favorable picture of device review and approval times than prior-year reports. For pre-market approval applications, total FDA review time decreased from 2006 to 2008, from 344 FDA days to 225 FDA days, according to the report. Complete numbers are not in for 2009. FDA's average time for 510(k) review, which had trended upward in recent years, is leveling off, the report noted. Average 510(k) review time went from 54 FDA days in 2005 to a peak of 67 days in 2007, decreasing to 65 days in 2008 and 63 days in 2009 (but the recent cohorts are not yet complete). FDA approved three de novo applications, for lower-risk devices that cannot be cleared via traditional 510(k), in fiscal 2009
Regulatory News In Brief
Office of Device Evaluation annual report: The device review office's fiscal 2009 annual report, released Sept. 2, paints a more favorable picture of device review and approval times than prior-year reports. For pre-market approval applications, total FDA review time decreased from 2006 to 2008, from 344 FDA days to 225 FDA days, according to the report. Complete numbers are not in for 2009. FDA's average time for 510(k) review, which had trended upward in recent years, is leveling off, the report noted. Average 510(k) review time went from 54 FDA days in 2005 to a peak of 67 days in 2007, decreasing to 65 days in 2008 and 63 days in 2009 (but the recent cohorts are not yet complete). FDA approved three de novo applications, for lower-risk devices that cannot be cleared via traditional 510(k), in fiscal 2009